https://www.zacks.com/stock/news/2246931/viking-vktx-up-17-on-encouraging-oral-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246931
Mar 27, 2024 - Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
zc:-2560310555373732512
0
https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297
Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
zc:-7881593380053313524
0
https://www.zacks.com/stock/news/2246106/wall-street-awaits-consumer-confidence-data?cid=CS-ZC-FT-economic_highlights-2246106
Mar 26, 2024 - Wall Street Awaits Consumer Confidence Data
zc:-7151330197196557010
0
https://www.zacks.com/stock/news/2245863/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245863
Mar 26, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
zc:242395152607255597
0
https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001
Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
0
fool:4246263758366513347
0
https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/?source=iedfolrf0000001
Mar 17, 2024 - There's no need for delays in buying these great stocks.
0
fool:-3883354788635643214
0
https://www.zacks.com/stock/news/2241318/madrigal-mdgl-stock-up-as-fda-approves-first-drug-for-nash?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2241318
Mar 15, 2024 - Madrigal Pharmaceuticals' (MDGL) Rezdiffra (resmetirom) is the first and only medicine approved by the FDA for the treatment of NASH.
zc:7416270046843019976
0
https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296
Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
zc:-4303199437016293624
0
https://www.fool.com/investing/2024/03/09/the-best-stocks-to-invest-50000-in-right-now/?source=iedfolrf0000001
Mar 09, 2024 - These stalwart companies can help you grow your wealth.
0
fool:-6220636149424077753
0
https://www.zacks.com/stock/news/2238098/s-p-500-soars-to-new-highs-5-best-stocks-ytd?cid=CS-ZC-FT-etf_news_and_commentary-2238098
Mar 08, 2024 - The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year.
zc:-4418631746276571622
0